Empagliflozin + Metformin hydrochloride combination tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Empagliflozin + Metformin hydrochloride combination tablet, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) [Phase 1]